Related Experiment Videos
Retrolental fibroplasia today
The Medical Journal of Australia
|March 21, 1981
Insights
Retinopathy of prematurity (RLF) is rising in premature infants. Despite advanced monitoring, hyperoxia remains a significant risk factor for this condition.
Area of Science:
- Neonatal ophthalmology
- Perinatal medicine
Background:
- Increasing survival rates of premature infants, particularly those with low birth weight, have led to a rise in retrolental fibroplasia (RLF), also known as retinopathy of prematurity.
- RLF affects approximately 17% of at-risk premature neonates, though most cases resolve spontaneously.
Purpose of the Study:
- To review current knowledge and management strategies for retinopathy of prematurity (RLF).
- To emphasize the persistent challenges posed by hyperoxia in RLF, even with advanced monitoring techniques.
Main Methods:
- Literature review of current knowledge on RLF.
- Analysis of RLF incidence and outcomes in premature neonates.
- Discussion of hyperoxia as a contributing factor.
Main Results:
- The incidence of RLF is increasing due to improved survival rates in premature infants.
- A significant percentage of at-risk infants develop RLF, but spontaneous resolution is common.
- Advanced monitoring has not eradicated the risks associated with hyperoxia.
Conclusions:
- Effective management of RLF requires continued vigilance regarding hyperoxia.
- Further research into preventing and managing RLF in premature infants is warranted.
- The interplay between prematurity, oxygen management, and RLF necessitates a comprehensive approach.
Abstract:
The incidence of retrolental fibroplasia (RLF, retinopathy of prematurity) is increasing, as more premature infants of lower birth weight are surviving. Currently, about 17% of premature neonates at risk will develop this condition, although in 85% of these cases it will undergo spontaneous resolution. This paper reviews our current knowledge and management of RLF, and aims to remind us that sophisticated monitoring techniques have not eliminated the problems of hyperoxia.